Get SKYCLARYS

Start your Friedreich
ataxia treatment
journey with
SKYCLARYS

Interested in SKYCLARYS?

Here’s how the SKYCLARYS prescription process works

Biogen REACH is an informational and support resource for you and your caregivers to explore ways to access SKYCLARYS.

Step 1

Ask your doctor if SKYCLARYS is right for you

Step 2

If so, ask your doctor to complete a physician
Start Form

Step 3

Ask your doctor to fax the Start Form to Biogen REACH 1-844-806-1718

From there, Biogen REACH will contact both you and your doctor to facilitate your prescription access.

Additional Biogen REACH support

You do not have to enroll in Biogen REACH support offerings to access prescribed SKYCLARYS.

Care Navigators
care navigator icon
 

They can help eligible patients navigate the SKYCLARYS journey as well as help with questions about:

  • Insurance and copay
    •  
     
  • Copay assistance
    •  
     
  • At-home prescription delivery
    •  
     
 
 

See more details

Specialty pharmacy
specialty pharmacy icon
 

Your SKYCLARYS prescription will be delivered to you by a specialty pharmacy

 

The Biogen REACH exclusive specialty pharmacy, Biologics, will contact you to confirm the delivery address and collect any copayments or coinsurance that may be required for each monthly supply of your SKYCLARYS prescription. SKYCLARYS is not available at retail pharmacies.

 

The specialty pharmacy may also contact you to inquire about your:

  • SKYCLARYS prescription
    •  
     
  • Insurance benefits and copays
    •  
     
  • Ability to get copay assistance
    •  
     
 
 

See more details

Affordability options
affordability icon
 

Options may be available to help you afford your SKYCLARYS prescription whether you are insured, underinsured, or uninsured.* Once enrolled in Biogen REACH, you may speak with a Care Navigator who can help you explore your eligibility for affordability options by calling 1-844-98-REACH.

 
 

*Subject to eligibility and program terms and conditions. Biogen REACH affordability options are not healthcare insurance.

 
 

See more details

Download Biogen REACH Brochure
Explore SKYCLARYS and community resources
Find resources

INDICATION AND IMPORTANT SAFETY INFORMATION

WHAT IS SKYCLARYS?

  • SKYCLARYS is used for the treatment of Friedreich ataxia in adults and children 16 years of age and older. It is not known if SKYCLARYS is safe and effective for use in children younger than 16 years of age

IMPORTANT SAFETY INFORMATION

What are the possible side effects of SKYCLARYS?

SKYCLARYS may cause serious side effects, including:

  • Increase in blood liver enzymes: Some people taking SKYCLARYS have had an increase in the level of liver enzymes in their blood. Your healthcare provider will do liver function tests
    • before you start taking SKYCLARYS
    • every month for the first 3 months after starting your treatment with SKYCLARYS
    • during certain times as needed while taking SKYCLARYS
    If your liver enzymes increase, your healthcare provider may change your dose, stop treatment for some time, or completely stop treatment with SKYCLARYS.
  • Increase in a blood protein called B-Type Natriuretic Peptide (BNP). BNP tells how well your heart is working. Your healthcare provider will check your BNP levels before your treatment with SKYCLARYS. Tell your healthcare provider if you have signs and symptoms of your heart not working well such as too much fluid in your body (fluid overload). Signs and symptoms may include:
    • sudden weight gain (3 pounds or more of weight gain in 1 day, or 5 pounds or more of weight gain in 1 week)
    • swelling in your arms, hands, legs, or feet (peripheral edema)
    • fast heartbeat (palpitations)
    • shortness of breath

    If you have symptoms of fluid overload that is considered a side effect of SKYCLARYS, your healthcare provider may stop treatment with SKYCLARYS.

  • Changes in cholesterol levels. Increases in low density lipoprotein cholesterol (LDL-C) or bad cholesterol and decreases in high density lipoprotein cholesterol (HDL-C) or good cholesterol have happened during treatment with SKYCLARYS. Your healthcare provider will check your cholesterol levels before and during your treatment with SKYCLARYS
 
 

The most common side effects of SKYCLARYS include: increased liver enzymes (ALT/AST), headache, nausea, stomach pain, tiredness, diarrhea, and muscle pain.

 
 

Before taking SKYCLARYS, tell your healthcare provider about all of your medical conditions, including if you:

  • have liver problems
  • have a history of heart problems, including heart failure
  • have a high level of fat in your blood (high blood cholesterol)
  • are pregnant or plan to become pregnant. It is not known if SKYCLARYS will harm your unborn baby. Women who use hormonal birth control should use another form of birth control such as a non-hormonal intrauterine system or an extra non-hormonal birth control such as condoms while using SKYCLARYS and for 28 days after stopping SKYCLARYS
  • are breastfeeding or plan to breastfeed. It is not known if SKYCLARYS passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you take SKYCLARYS
 
 

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements such as St. John’s Wort.

  • Taking SKYCLARYS with other medicines can cause serious side effects
  • SKYCLARYS may affect the way other medicines work, and other medicines may affect how SKYCLARYS works
  • Know the medicines you take. Keep a list of them to show to your healthcare provider and pharmacist when you get a new medicine
 
 

What should I avoid while taking SKYCLARYS?

  • Do not drink grapefruit juice or eat grapefruit. These may change the amount of SKYCLARYS in your blood

These are not all the possible side effects of SKYCLARYS. For more information, ask your healthcare provider or pharmacist.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see full Prescribing Information, including Patient Information.

Intended for a US audience.

©2024 Biogen. All rights reserved. SKY-US-0221 v3 10/2024

©2024 Biogen. All rights reserved. SKY-US-0222 v3 10/2024